Ovarian cancer in infertility patients

Annals of Medicine

Volumn 30, Issue 6, 1998, Pages 525-528

  Burmeister, Lynette ^a   Healy, David L ^a  

^a MONASH UNIVERSITY   (Australia)

Author keywords

Endometriosis; In vitro fertilization; Infertility; Ovarian cancer

Indexed keywords

CLOMIFENE CITRATE;

CANCER RISK; DISEASE ASSOCIATION; ENDOMETRIOSIS; FEMALE; FEMALE INFERTILITY; HUMAN; INFERTILITY THERAPY; OVARY CANCER; OVULATION INDUCTION; PRIORITY JOURNAL; REVIEW;

EID: 0032423393     PISSN: 07853890     EISSN: None     Source Type: Journal    
DOI: 10.3109/07853899809002599     Document Type: Review

References (18)

1. Whittemore AS. Fertility drugs and risk of ovarian cancer. Hum Reprod 1993; 8: 999-1000.
2. Shoham Z. Epidemiology, etiology and fertility drugs in ovarian cancer: where are we today? Fertil Steril 1994; 62: 433-48.
3. Kaufman SC, Spirtas R, Alexander N. Do fertility drugs cause ovarian tumours? J Womens Health 1995; 4: 247-59.
4. Modan B, Ron E, Lerner-Geva L, et al. Cancer incidence in a cohort of infertile women. Am J Epidemiol 1988; 147: 1038-42.
5. Shu XO, Brinton LA, Gao YT, Yuan JM. Population-based case-control study of ovarian cancer in Shanghai. Cancer Res 1989; 49: 3670-4.
6. Whittemore AS, Harris R, Itnyre J. Characteristics relating to ovarian cancer risk: collaborative analysis of 12 US case-control studies. II. Invasive epithelial ovarian cancers in white women. Collaborative Ovarian Cancer Group. Am J Epidemiol 1992: 136: 1184-203.
7. Harris R, Whittemore AS, Itnyre J. Characteristics relating to ovarian cancer risk: collaborative analysis of 12 US case-control studies. III. Epithelial tumors of low malignant potential in white women. Collaborative Ovarian Cancer Group. Am J Epidemiol 1992; 136: 1204.
8. Whittemore AS, Harris R, Itnyre J. Characteristics relating to ovarian cancer risk: collaborative analysis of 12 US case-control studies. IV. The pathogenesis of epithelial ovarian cancer. Collaborative Ovarian Cancer Group. Am J Epidemiol 1992; 136: 1212-20.
9. Spirtal R, Kaufman S, Alexander N. Fertility drugs and ovarian cancer: red alert or red herring? Fertil Steril 1993; 59: 291-3.
10. International Federation of Fertility Societies (IFFS). Fertility drugs and ovarian cancer. Fertil Steril 1993; 60: 406-8.
11. Rossing MA, Daling JR, Weiss NS, Moore DE, Self SG. In situ and invasive cervical carcinoma in a cohort of infertile women. Fertil Steril 1996; 65: 19-22.
12. Rossing MA, Daling JR, Weiss NS, Moore DE, Self SG. Ovarian tumours in a cohort of infertile women. N Eng J Med 1994; 331: 771-6.
13. Mosgaard BJ, Lidegaard O, Andersen AN. The impact of parity, infertility and treatment with fertility drugs on the risk of ovarian cancer. A survey. Acta Obstet Gynecol Scand 1997; 76: 89-95.
14. Shushan A, Paltiel, Iscovich J, Elchalal U, Peretz T, Schenker J. Human menopausal gonadotrophin and the risk of epithelial ovarian cancer. Fertil Steril 1996; 65: 13-8.
15. Parazzini F, Negri E, La Vecchio C, et al. Treatment for fertility and risk of ovarian tumours of borderline malignancy. Gynecol Oncol 1998; 69: 226-8.
16. Venn A, Watson L, Lumley J, Giles G, King C, Healy D. Breast and ovarian cancer incidence after infertility and in vitro fertilisation. Lancet 1995; 346: 995-1000.
17. Mosgaard BJ, Lidegaard O, Kjaer SK, Schou G, Andersen AN. Infertility, fertility drugs and invasive ovarian cancer: a case control study. Fertil Steril 1997; 67: 1005-12.
18. Brinton LA, Gridley G, Persson I, Baron J, Bergqvist A. Cancer risk after a hospital discharge diagnosis of endometriosis. Am J Obstet Gynecol 1997; 176: 572-9.